Fresenius Medical Care AG (FMS) Stock Price, News, Quote & History

Fresenius Medical Care AG (FMS) stock price, news, quote and history

FMS Launches multiFiltratePRO System for U.S. Patients With Acute AKI

A new ICU kidney system works without separate pumps for its treatment fluids.

Fresenius Medical Care Brings Kidney Care Innovation to Critical Care Patients with U.S. Launch of multiFiltratePRO™

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Stock Has Consensus Target Price of $23.42 According to Analysts

A class of diabetes drugs was linked to fewer deaths and hospital stays in about 5,000 dialysis patients.

Fresenius Medical Care presents new evidence and innovations advancing kidney care at ASN Kidney Week 2026

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Stock Gets Price Target Cut from Truist Financial

Shervin J. Korangy appointed CEO of Fresenius Medical Care to lead the next phase of strategic development and long-term profitable growth

Fresenius Medical Care Reshapes China Portfolio for Long-Term Growth

Fresenius Medical Care Refines China Commercial Strategy with a Focus on Long-Term Growth and Market Leadership

Fresenius Medical Care AG (FMS) Stock Down 3.9% -- Now Undervalued? GF Score: 74/100

FDA Slams Fresenius Over Leaking Dialysis Bags, Warns of Potentially Life-Threatening Risk

Can Fresenius Medical's 5008X Rollout Drive the Next Growth Phase?